Northern Trust Corp Sqz Biotechnologies CO Transaction History

Northern Trust Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.77 - $5.0 $416,926 - $752,575	-150,515 Reduced 82.91%	31,022 $99,000
Q1 2022 May 13, 2022	SELL	$4.01 - $10.42 $52,655 - $136,825	-13,131 Reduced 6.75%	181,537 $873,000
Q4 2021 Feb 08, 2022	BUY	$8.93 - $14.85 $285 - $475	32 Added 0.02%	194,668 $1.74 Million
Q3 2021 Nov 15, 2021	BUY	$11.46 - $15.77 $125,624 - $172,870	10,962 Added 5.97%	194,636 $2.81 Million
Q2 2021 Aug 13, 2021	BUY	$11.32 - $14.45 $1.35 Million - $1.73 Million	119,662 Added 186.94%	183,674 $2.65 Million
Q1 2021 May 12, 2021	BUY	$12.07 - $29.9 $112,299 - $278,189	9,304 Added 17.01%	64,012 $875,000
Q4 2020 Feb 11, 2021	BUY	$13.25 - $34.58 $724,881 - $1.89 Million	54,708 New	54,708 $1.59 Million

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.